Colin Dingwall
Title and authors | Publication | Year |
---|---|---|
Proteasome activity modulates amyloid toxicity.
Galvin J, Curran E, Arteaga F, Goossens A, Aubuchon-Endsley N, McMurray MA, Moore J, Hansen KC, Chial HJ, Potter H, Brodsky JL, Coughlan CM |
FEMS Yeast Research | 2022 |
Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease
Mukerjee N, Das A, Jawarkar RD, Maitra S, Das P, Castrosanto MA, Paul S, Samad A, Zaki ME, Al-Hussain SA, Masand VH, Hasan MM, Bukhari SN, Perveen A, Alghamdi BS, Alexiou A, Kamal MA, Dey A, Malik S, Bakal RL, Abuzenadah AM, Ghosh A, Md Ashraf G |
Frontiers in aging neuroscience | 2022 |
From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.
Alarcón-Espósito J, Mallea M, Rodríguez-Lavado J |
Current neuropharmacology | 2021 |
Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer′s disease mice
G Chai, Y Wang, A Yasheng, P Zhao |
NEURAL REGEN RES | 2016 |
Comparative molecular field analysis and comparative molecular similarity indices analysis of hydroxyethylamine derivatives as selective human BACE-1 inhibitor
A Pandey, J Mungalpara, CG Mohan |
Molecular Diversity | 2009 |
Targeted delivery of proteins across the blood-brain barrier
BJ Spencer, IM Verma |
Proceedings of the National Academy of Sciences | 2007 |
Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast
LJ Sparvero, S Patz, JL Brodsky, CM Coughlan |
Analytical Biochemistry | 2007 |
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
MT Heneka, M Sastre, L Dumitrescu-Ozimek, I Dewachter, J Walter, T Klockgether, FV Leuven |
Journal of Neuroinflammation | 2005 |